These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31708337)

  • 41. Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo.
    Rosenblum WI; Nelson GH; Wormley B; Werner P; Wang J; Shih CC
    Stroke; 1996 Apr; 27(4):709-11. PubMed ID: 8614936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Uematsu T
    Circulation; 1997 Aug; 96(4):1299-304. PubMed ID: 9286962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Clopidogrel on Thrombus Formation in an Ex Vivo Parallel Plate Flow Chamber Model Cannot Be Reversed by Addition of Platelet Concentrates or vWF Concentrate.
    Jahn K; Suchodolski K; Schäfer A; Sahlmann B; Küster U; Echtermeyer F; Calmer S; Theilmeier G; Johanning K
    Anesth Analg; 2017 Apr; 124(4):1091-1098. PubMed ID: 28244953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits.
    Greenlees C; Wadsworth RM; Martorana PA; Wainwright CL
    Cardiovasc Res; 1997 Aug; 35(2):351-9. PubMed ID: 9349398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous Iliac Vein Bovine Pericardial Patch Venoplasty and Creation of PTFE Lower Limb Arteriovenous Fistula Graft for Rescue Vascular Access.
    Meecham L; Fisher O; Kirby G; Evans R; Buxton P; Legge J; Rajagopalan S; Asquith J; Pherwani A
    Ann Vasc Surg; 2016 Oct; 36():292.e9-292.e11. PubMed ID: 27423716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Injury induces increase of von Willebrand factor in rat endothelial cells.
    Reidy MA; Chopek M; Chao S; McDonald T; Schwartz SM
    Am J Pathol; 1989 Apr; 134(4):857-64. PubMed ID: 2650559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant leech antiplatelet protein specifically blocks platelet deposition on collagen surfaces under flow conditions.
    van Zanten GH; Connolly TM; Schiphorst ME; de Graaf S; Slootweg PJ; Sixma JJ
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1424-31. PubMed ID: 7670958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of an absorbable collagen cover (NeuraWrap) improves patency of interpositional vein grafts.
    Bekler HI; Rosenwasser MP; Akilina Y; Bulut G
    Acta Orthop Traumatol Turc; 2010; 44(2):157-61. PubMed ID: 20676019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis.
    Pavo N; Samaha E; Sabdyusheva I; von Strandmann RP; Stahnke S; Plass CA; Zlabinger K; Lukovic D; Jambrik Z; Pavo IJ; Bergler-Klein J; Gray WA; Maurer G; Gyöngyösi M
    J Mater Sci Mater Med; 2016 Aug; 27(8):131. PubMed ID: 27388164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.
    Gertz SD; Fallon JT; Gallo R; Taubman MB; Banai S; Barry WL; Gimple LW; Nemerson Y; Thiruvikraman S; Naidu SS; Chesebro JH; Fuster V; Sarembock IJ; Badimon JJ
    Circulation; 1998 Aug; 98(6):580-7. PubMed ID: 9714116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease.
    Makin AJ; Chung NA; Silverman SH; Lip GY
    Pathophysiol Haemost Thromb; 2002; 32(4):158-64. PubMed ID: 12759516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
    Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis.
    Fuster V; Griggs TR
    Prog Hemost Thromb; 1986; 8():159-83. PubMed ID: 3550894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.
    Cyrus T; Zhang H; Allen JS; Williams TA; Hu G; Caruthers SD; Wickline SA; Lanza GM
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):820-6. PubMed ID: 18292395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electro-encapsulating drugs within blood platelets: local delivery to injured arteries during angioplasty.
    Crawford N; Chronos N
    Semin Interv Cardiol; 1996 Mar; 1(1):91-102. PubMed ID: 9552499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment with nesiritide, a recombinant B-type natriuretic Peptide, reduces vascular remodeling following balloon-induced endothelial injuries in rabbits.
    Liu SQ; Yu YY; Xie HW; Yu K; Wang LX
    Tohoku J Exp Med; 2010 Nov; 222(3):219-23. PubMed ID: 21079380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.
    Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.
    Bae ON
    Arch Pharm Res; 2012 Oct; 35(10):1693-9. PubMed ID: 23139119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vascular wall hypoxia promotes arterial thrombus formation via augmentation of vascular thrombogenicity.
    Matsuura Y; Yamashita A; Iwakiri T; Sugita C; Okuyama N; Kitamura K; Asada Y
    Thromb Haemost; 2015 Jul; 114(1):158-72. PubMed ID: 25833755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.